Arcadia Biosciences, Inc.·4

Sep 20, 7:27 PM ET

Reiter Sarah 4

4 · Arcadia Biosciences, Inc. · Filed Sep 20, 2018

Insider Transaction Report

Form 4
Period: 2018-09-18
Reiter Sarah
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-09-18+38,40048,400 total
    Exercise: $4.63From: 2018-10-30Exp: 2028-09-18Common Stock (38,400 underlying)
Footnotes (1)
  • [F1]The options will vest monthly in equal installments over a period of two years from the date of the grant, subject to the Participant's continued service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION